COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 638: Articles 6371-6380  | Next

SARS-CoV-2 Airway Infection Results in Time-dependent Sensory Abnormalities in a Hamster Model
Serafini, R. A., Frere, J. J., Zimering, J., Giosan, I. M., Pryce, K. D., Golynker, I., Panis, M., Ruiz, A., tenOever, B., Zachariou, V.
10.1101/2022.08.19.504551 — Posted: 2022-08-19
Disrupted chromatin architecture in olfactory sensory neurons: A missing link from COVID-19 infection to anosmia
Tan, Z. W., Toon, P. J., Guarnera, E., Berezovsky, I. N.
10.1101/2022.08.19.504545 — Posted: 2022-08-19
Single-cell RNA sequencing highlights a reduced function of natural killer and cytotoxic T cells in recovered COVID-19 pregnant women
Aziz, N. H. A., Salker, M. S., Lankapalli, A. K., Shafiee, M. N., Kocak, E., Shekhar, S. P., Khalid, O., Kasim, N. M., Kalok, A., Fuad, N. A., Ossowski, S., Casadei, N., Deutsche COVID-19 OMICS Initiative (DeCOI), , Brucker, S. Y., Riess, O., Singh, Y.
10.1101/2022.08.18.504053 — Posted: 2022-08-19
Relative contributions of vaccination and previous infection to population-level SARS-CoV-2 immunity over time: a simulation modelling study
Szanyi, J., Wilson, T., Andrabi, H., Blakely, T.
10.1101/2022.08.18.22278963 — Posted: 2022-08-19
Within-host genetic diversity of SARS-CoV-2 in the context of large-scale hospital-associated genomic surveillance
Mushegian, A., Long, S. W., Olsen, R. J., Christensen, P. J., Subedi, S., Chung, M., Davis, J., Musser, J., Ghedin, E.
10.1101/2022.08.17.22278898 — Posted: 2022-08-19
Demographic and Outcome Characteristics of Children Hospitalized with Acute COVID-19 versus Multisystem Inflammatory Syndrome in Children in Canada
Farrar, D. S., Moore Hepburn, C., Drouin, O., El Tal, T., Morin, M.-P., Berard, R. A., King, M., Laffin Thibodeau, M., Haddad, E., Scuccimarri, R., Yeung, R. S. M., Kakkar, F., Morris, S. K., Canadian Paediatric Surveillance Program COVID-19 Study Team
10.1101/2022.08.18.22278939 — Posted: 2022-08-19
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
Witte, L., Baharani, V., Schmidt, F., Wang, Z., Cho, A., Raspe, R., Guzman-Cardozo, M. C., Muecksch, F., Gaebler, C., Caskey, M., Nussenzweig, M. C., Hatziioannou, T., Bieniasz, P. D.
10.1101/2022.08.17.504313 — Posted: 2022-08-19
Ancestral lineage of SARS-CoV-2 is more stable in human biological fluids than Alpha, Beta and Omicron variants of concern
Kwon, T., Gaudreault, N. N., Meekins, D., McDowell, C., Cool, K., Richt, J. A.
10.1101/2022.08.17.504362 — Posted: 2022-08-19
A syntenin inhibitor blocks endosomal entry of SARS-CoV-2 and a panel of RNA viruses
Lindqvist, R., Benz, C., Sereikaite, V., Maassen, L., Laursen, L., Jemth, P., Stromgaard, K., Ivarsson, Y., Overby, A. K.
10.1101/2022.08.18.504268 — Posted: 2022-08-19
How Have Global Scientists Responded to Tackling COVID-19?
Cao, L., Hou, W.
10.1101/2022.08.16.22278871 — Posted: 2022-08-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).